Which inhaler works best for COPD? new study aims to find out
NCT ID NCT07541378
First seen Apr 21, 2026 · Last updated May 19, 2026 · Updated 5 times
Summary
This study compares three different dual bronchodilator inhalers (Anoro, Ultibro, Spiolto) against a single bronchodilator (Spiriva) in people with COPD. The goal is to see which treatment best improves exercise endurance and quality of life. About 100 adults with stable COPD will try each treatment for 28 days, with a week off between each. The results may help doctors choose the most effective and cost-efficient therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
II Department of Lung Diseases, Lung Cancer and Internal Diseases
Bialystok, Podlaskie Voivodeship, 15-540, Poland
Conditions
Explore the condition pages connected to this study.